148
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

The Role of Patient Payment Method in Premature Discharge from Methadone Maintenance Treatment

ORCID Icon, , &
Pages 97-105 | Received 26 Jan 2018, Accepted 20 Jul 2018, Published online: 26 Oct 2018

References

  • Aliyu, Z. Y. (2002). Discharge against medical advice: Sociodemographic, clinical and financial perspectives. International Journal of Clinical Practice, 56, 325–327.
  • Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28(4), 321–329.
  • Anglin, D. M., Speckart, G. R., Booth, M. W., & Ryan, T. M. (1989). Consequences and costs of shutting off methadone. Addictive Behaviors, 14(3), 307–326. doi:10.1016/0306-4603(89)90062-2
  • Ball, J. C., Lange, W. R., Myers, C. P., & Friedman, S. R. (1988). Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior, 29(3), 214–226.
  • Baptist, A. P., Warrier, I., Arora, R., Ager, J., & Massanari, R. M. (2007). Hospitalized patients with asthma who leave against medical advice: Characteristics, reasons, and outcomes. Journal of Allergy and Clinical Immunology, 119(4), 924–929. doi:10.1016/j.jaci.2006.11.695
  • Bart, G. (2012). Maintenance medication for opiate addiction: The foundation of recovery. Journal of Addictive Diseases, 31(3), 207–225. doi:10.1080/10550887.2012.694598
  • Bao, Y.-P., Liu, Z.-M., Epstein, D. H., Du, C., Shi, J., & Lu, L. (2009). A meta-analysis of retention in methadone maintenance by dose and dosing strategy. The American Journal of Drug and Alcohol Abuse, 35(1), 28–33. doi:10.1080/00952990802342899
  • Brady, T. M., Salvucci, S., Sverdlov, L. S., Male, A., Kyeyune, H., Sikali, E., … Yu, P. (2005). Methadone dosage and retention. Journal of Addictive Diseases, 24(3), 23–47. doi:10.1300/j069v24n03_03
  • Brands, B., Blake, J., Marsh, D. C., Sproule, B., Jeyapalan, R., & Li, S. (2008). The impact of benzodiazepine use on methadone maintenance treatment outcomes. Journal of Addictive Diseases, 27(3), 37–48. doi:10.1080/10550880802122620
  • Brown, B. S., Watters, J. K., Iglehart, A. S., & Akins, C. (1982). Methadone maintenance dosage levels and program retention. The American Journal of Drug and Alcohol Abuse, 9(2), 129–139. doi:10.3109/00952998209002617
  • Deck, D., & Carlson, M. J. (2005). Retention in publicly funded methadone maintenance treatment in two western states. The Journal of Behavioral Health Services & Research, 32(1), 43–60. doi:10.1007/bf02287327
  • Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., & Burns, L. (2009). Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug and Alcohol Dependence, 105(1-2), 9–15. doi:10.1016/j.drugalcdep.2009.05.021
  • del Rio, M., Mino, A., & Perneger, T. V. (1997). Predictors of patient retention in a newly established methadone maintenance treatment programme. Addiction, 92(10), 1353–1360. doi:10.1111/j.1360-0443.1997.tb02854.x
  • Esteban, J., Gimeno, C., Barril, J., Aragones, A., Climent, J. M., & de la Cruz Pellin, M. (2003). Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment. Drug and Alcohol Dependence, 70(2), 193–200. doi:10.1016/s0376-8716(03)00002-4
  • Fugelstad, A., Stenbacka, M., Leifman, A., Nylander, M., & Thiblin, I. (2007). Methadone maintenance treatment: The balance between life-saving treatment and fatal poisonings. Addiction, 102(3), 406–412. doi:10.1111/j.1360-0443.2006.01714.x
  • Gryczynski, J., Schwartz, R. P., Salkever, D. S., Mitchell, S. G., & Jaffe, J. H. (2011). Patterns in admission delays to outpatient methadone treatment in the United States. Journal of Substance Abuse Treatment, 41(4), 431–439. doi:10.1016/j.jsat.2011.06.005
  • Hartel, D. M., & Schoenbaum, E. E. (1998). Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Reports, 113, 107–115.
  • Hser, Y.-I., Li, J., Jiang, H., Zhang, R., Du, J., Zhang, C., … Zhao, M. (2011). Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction, 106(10), 1801–1809. doi:10.1111/j.1360-0443.2011.03490.x
  • Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997). Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 261–278.
  • Joe, G. W., Simpson, D. D., & Broome, K. M. (1998). Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction (Abingdon, England), 93(8), 1177–1190.
  • Kelly, S. M., O’Grady, K. E., Mitchell, S. G., Brown, B. S., & Schwartz, R. P. (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence, 117(2-3), 170–175. doi:10.1016/j.drugalcdep.2011.01.008
  • Li, L., Ding, Y., Lai, W., Lin, C., & Luo, W. (2011). Motivational profiles of clients seeking methadone maintenance therapy in China. Drug and Alcohol Dependence, 118(2-3), 335–340.
  • Maddux, J. F., Prihoda, T. J., & Desmond, D. P. (1994). Treatment fees and retention on methadone maintenance. Journal of Drug Issues, 24(3), 429–443. doi:10.1177/002204269402400305
  • Magura, S., Nwakeze, P. C., & Demsky, S. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93(1), 51–60. doi:10.1046/j.1360-0443.1998.931516.x
  • Magura, S., Nwakeze, P. C., Kang, S., & Demsky, S. (1999). Program quality effects on patient outcomes during methadone maintenance: A study of 17 clinics. Substance Use & Misuse, 34(9), 1299–1324. doi:10.3109/10826089909039410
  • Mancino, M., Curran, G., Han, X., Allee, E., Humphreys, K., & Booth, B. M. (2010). Predictors of attrition from a national sample of methadone maintenance patients. The American Journal of Drug and Alcohol Abuse, 36(3), 155–160. doi:10.3109/00952991003736389
  • Muhleisen, P., Clark, N., Teo, A., & Brogan, D. (2005). Opioid substitution therapy: Considering the costs to consumers. SubStance, 3, 14– 17.
  • Murphy, S., & Rosenbaum, M. (1988). Money for methadone II: Unintended consequences of limited-duration methadone maintenance. Journal of Psychoactive Drugs, 20(4), 397–402. doi:10.1080/02791072.1988.10472508
  • Nosyk, B., Li, L., Evans, E., Urada, D., Huang, D., Wood, E., … Hser, Y.-I. (2014). Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publically-funded facilities in California, USA: 1991-2012. Drug and Alcohol Dependence, 143, 149–157.
  • Nosyk, B., Geller, J., Guh, D. P., Oviedo-Joekes, E., Brissette, S., Marsh, D. C., … Anis, A. H. (2010). The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study. Drug and Alcohol Dependence, 111(1-2), 161–165. doi:10.1016/j.drugalcdep.2010.03.019
  • Potter, J. S., Marino, E. N., Hillhouse, M. P., Nielsen, S., Wiest, K., Canamar, C. P., … Ling, W. (2013). Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: Findings from Starting Treatment with Agonist Replacement Therapies (START). Journal of Studies on Alcohol and Drugs, 74(4), 605–613.
  • Proctor, S. L., Copeland, A. L., Kopak, A. M., Hoffmann, N. G., Herschman, P. L., & Polukhina, N. (2015). Predictors of patient retention in methadone maintenance treatment. Psychology of Addictive Behaviors, 29(4), 906–917. doi:10.1037/adb0000090
  • Reisinger, H. S., Schwartz, R. P., Mitchell, S. G., Peterson, J. A., Kelly, S. M., O'Grady, K. E., … Agar, M. H. (2009). Premature discharge from methadone treatment: Patient perspectives. Journal of Psychoactive Drugs, 41(3), 285–296. doi:10.1080/02791072.2009.10400539
  • Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016). Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. Mmwr. Morbidity and Mortality Weekly Report, 65(5051), 1445–1452. doi:10.15585/mmwr.mm6550e1.
  • Saxon, A. J., Wells, E. A., Fleming, C., Jackson, T. R., & Calsyn, D. A. (1996). Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction, 91(8), 1197–1210. doi:10.1046/j.1360-0443.1996.918119711.x
  • Simpson, D. D., Joe, G. W., Broome, K. M., Hiller, M. L., Knight, K., & Rowan-Szal, G. A. (1997). Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 279–293. doi:10.1037//0893-164x.11.4.279
  • Soyka, M., Apelt, S. M., Lieb, M., & Wittchen, H. (2006). One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy. Journal of Clinical Psychopharmacology, 26(6), 657–660. doi:10.1097/01.jcp.0000245561.99036.49
  • Substance Abuse and Mental Health Services Administration (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Rockville: Substance Abuse and Mental Health Services Administration.
  • Substance Abuse and Mental Health Services Administration (2017). Behavioral Health Barometer: Indicators as measured through the 2015 National Survey on Drug Use and Health and National Survey of Substance Abuse Treatment Services. Center for Behavioral Health Statistics and Quality, HHS Publication No. SMA–17–BaroUS–16. Rockville: Substance Abuse and Mental Health Services Administration.
  • Torrens, M., Castillo, C., & Pérez-Solá, V. (1996). Retention in a low-threshold methadone maintenance program. Drug and Alcohol Dependence, 41(1), 55–59. doi:10.1016/0376-8716(96)01230-6
  • U.S. Department of Health and Human Services (2016). Facing addiction in America: The surgeon general’s report on alcohol, drugs, and health. Office of the Surgeon General. Washington, DC: U.S. Department of Health and Human Services.
  • Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014). Medication-assisted therapies-Tackling the opioid-overdose epidemic. New England Journal of Medicine, 370(22), 2063–2066.
  • Williams, I. (2015). Is administrative discharge an archaic or synchronic program practice? The empirical side of the debate. Online Journal of Health Ethics, 11(2), 1–5. doi:10.18785/ojhe.1102.06
  • Wong, E. C., & Longshore, D. (2008). Ethnic identity, spirituality, and self-efficacy influences on treatment outcomes among Hispanic American methadone maintenance clients. Journal of Ethnicity in Substance Abuse, 7(3), 328–340. doi:10.1080/15332640802313478
  • Woody, G. E., Kane, V., Lewis, K., & Thompson, R. (2007). Premature deaths after discharge from methadone maintenance: A replication. Journal of Addiction Medicine, 1(4), 180–185. doi:10.1097/adm.0b013e318155980e
  • Zanis, D. A., & Woody, G. E. (1998). One-year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence, 52(3), 257–260.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.